1. Home
  2. TRDA vs WEYS Comparison

TRDA vs WEYS Comparison

Compare TRDA & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRDA
  • WEYS
  • Stock Information
  • Founded
  • TRDA 2016
  • WEYS 1906
  • Country
  • TRDA United States
  • WEYS United States
  • Employees
  • TRDA N/A
  • WEYS N/A
  • Industry
  • TRDA Biotechnology: Pharmaceutical Preparations
  • WEYS Apparel
  • Sector
  • TRDA Health Care
  • WEYS Consumer Staples
  • Exchange
  • TRDA Nasdaq
  • WEYS Nasdaq
  • Market Cap
  • TRDA 301.0M
  • WEYS 303.2M
  • IPO Year
  • TRDA 2021
  • WEYS N/A
  • Fundamental
  • Price
  • TRDA $7.12
  • WEYS $30.03
  • Analyst Decision
  • TRDA Strong Buy
  • WEYS
  • Analyst Count
  • TRDA 3
  • WEYS 0
  • Target Price
  • TRDA $25.67
  • WEYS N/A
  • AVG Volume (30 Days)
  • TRDA 126.5K
  • WEYS 12.0K
  • Earning Date
  • TRDA 08-12-2025
  • WEYS 08-05-2025
  • Dividend Yield
  • TRDA N/A
  • WEYS 9.95%
  • EPS Growth
  • TRDA N/A
  • WEYS N/A
  • EPS
  • TRDA 0.61
  • WEYS 3.04
  • Revenue
  • TRDA $172,220,000.00
  • WEYS $286,762,000.00
  • Revenue This Year
  • TRDA N/A
  • WEYS N/A
  • Revenue Next Year
  • TRDA N/A
  • WEYS N/A
  • P/E Ratio
  • TRDA $11.70
  • WEYS $10.13
  • Revenue Growth
  • TRDA 5.74
  • WEYS N/A
  • 52 Week Low
  • TRDA $6.94
  • WEYS $25.51
  • 52 Week High
  • TRDA $21.79
  • WEYS $41.05
  • Technical
  • Relative Strength Index (RSI)
  • TRDA 36.18
  • WEYS 42.59
  • Support Level
  • TRDA $6.94
  • WEYS $29.30
  • Resistance Level
  • TRDA $8.49
  • WEYS $33.22
  • Average True Range (ATR)
  • TRDA 0.42
  • WEYS 0.88
  • MACD
  • TRDA -0.07
  • WEYS -0.22
  • Stochastic Oscillator
  • TRDA 10.91
  • WEYS 18.62

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

Share on Social Networks: